Welcome to our dedicated page for Check Cap SEC filings (Ticker: CHEK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Check-Cap Ltd. (NASDAQ: CHEK) SEC filings page on Stock Titan aggregates the company’s U.S. regulatory disclosures, offering investors direct access to official information about its business, strategic transactions and compliance status. As a foreign private issuer, Check-Cap files annual reports on Form 20-F and furnishes current reports on Form 6-K, which are frequently incorporated by reference into its registration statements on Form F-3 and Form S-8.
Recent Form 6-K filings detail the company’s transformational merger with MBody AI Corp., a Nevada-based embodied artificial intelligence company. These reports include the Agreement and Plan of Merger, shareholder meeting results approving the merger and related proposals, and a proposal to change the company’s name to “MBody AI Ltd.” at the effective time of the transaction. Other 6-Ks describe Nasdaq correspondence on listing requirements, including minimum bid price, stockholders’ equity and periodic filing obligations, as well as the company’s responses and subsequent compliance updates.
Filings also document Check-Cap’s acquisition of exclusive Ghost Kitchen franchise rights in New Jersey through an Asset Purchase Agreement, outlining the consideration paid in ordinary shares and the revenue-sharing structure for franchise fees and royalties. Historical disclosures provide background on Check-Cap’s legacy medical diagnostics business, including its C-Scan® investigational device for colorectal cancer screening and related intellectual property.
On Stock Titan, these filings are supplemented by AI-powered summaries that explain the key points of lengthy documents, helping readers interpret complex legal and financial language. Investors can review annual reports (Form 20-F) for a comprehensive discussion of operations and risk factors, and use current reports (Form 6-K) to track material events such as mergers, financing plans, Nasdaq communications and significant business updates. Together, the CHEK filings offer a detailed regulatory record of the company’s shift from medical diagnostics toward embodied AI and automation.
Check-Cap (CHEK) furnished a Form 6-K highlighting MBody AI’s enterprise traction and an upcoming merger vote on November 14. The filing describes MBody AI’s hardware-agnostic Orchestrator platform as the integration layer for robots and intelligent devices across factories, hotels, hospitals, and data centers. Reported outcomes from organizations using the platform include up to 40 percent labor reduction and 80 percent uptime improvement.
MBody AI notes multi-year, multi-million-dollar enterprise contracts, Fortune 500 and blue-chip deployments, and growing investor interest from major funds, family offices, and strategics totaling into the hundreds of millions of dollars. Company leaders frame the merger as positioning CHEK shareholders within embodied AI, supported by forward-looking statements that caution that actual results may differ due to market conditions, regulatory approvals, and integration risks.
Check-Cap Ltd. (CHEK) rescheduled its Annual General Meeting to November 14, 2025 at 10:00 a.m. ET at Paul Hastings LLP in Washington, DC. Shareholders of record as of September 16, 2025 may vote. The proxy materials previously furnished are incorporated by reference, with an updated Reverse Split Proposal range of 1-for-2 to 1-for-100. The number of authorized ordinary shares will remain 18,000,000, and the nominal value will remain NIS 48.0 per share even if the reverse split is approved.
The company also provided an update on its proposed merger with MBody AI. Under the September 12, 2025 Merger Agreement, a Check-Cap subsidiary will merge into MBody AI, which will survive as a wholly owned subsidiary of Check-Cap. The Board affirmed that the originally disclosed exchange ratio is being preserved. Subject to satisfaction or waiver of closing conditions and shareholder approval, the parties expect to consummate the merger in the weeks following approval.
Check-Cap (CHEK) furnished a business update on its pending merger with MBody AI and recent market activity. The company reported exceptional capital-markets engagement following the merger announcement, noting its shares increased by more than 300% and trading volumes reached the hundreds of millions of dollars in the days after the news.
The Board is evaluating potential financing opportunities to support the combined company’s growth strategy. No securities are being offered by this Form 6-K; any future financing would be conducted in compliance with applicable laws and regulations.
To allow additional time to assess financing options and amid elevated investor engagement, Check-Cap will reschedule its Annual General Meeting of Shareholders (originally set for October 17, 2025) and expects to announce a new date and record date in a subsequent Form 6-K.
Check-Cap Ltd. reports that Nasdaq has restored its compliance status with the periodic filing rule after the company submitted its Annual Report on Form 20-F for the year ended December 31, 2024. However, Nasdaq has now notified the company that it no longer meets the stockholders’ equity requirement of
Separately, on